The T cell and macrophage occupancy of the CCR5 receptor was zero for each patient before leronlimab injection. The median occupancy on Days 3, 7, and 14 for patients A, B and C was approximately ≥80% (Fig. 1f)

https://www.sciencedirect.com/science/article...9021000034